Delivery Order SPE2DB24D2003-SPE2DB25FXMV8
- Not listed
- The Defense Logistics Agency awarded a $10,960.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $17,186.02 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,661.45 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract type. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive, non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a $3,668.62 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,616.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count packages). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award to the established pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price arrangement. The contract, valued at $27,148.14, was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $7,553.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) with a ceiling value of $1,563.57. This non-set-aside, firm fixed price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29,014 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive procurement requiring delivery to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract valued at $32,928.71. The award, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMV8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count) under a firm fixed price contract valued at $26,680.56, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply chain support to federal healthcare systems, including the Defense Health Agency and the U.S. Coast Guard. The delivery order reflects AmerisourceBergen's ongoing role as a primary pharmaceutical vendor supporting military healthcare programs. The company's extensive federal contract portfolio demonstrates its capacity to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains, from specialty medications to vaccines and medical devices. As DLA Troop Support moves toward establishing next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, AmerisourceBergen remains positioned as a key strategic supplier for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.7k | 9/17/25 |